Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor-F Mautner

Showing results (51-60 of 72) with videos related to

Pageof 8
Sort By:
Carcinogenesis|December 17, 2005
Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivityNikola Holtkamp, Ali Fuat Okuducu, Jana Mucha, et al.
EJNMMI Research|December 27, 2024
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 - intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imagingInka Ristow, Ivayla Apostolova, Michael G Kaul, et al.
Neuro-Oncology|November 30, 2018
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imagingLennart Well, Johannes Salamon, Michael G Kaul, et al.
Neuro-Oncology Advances|March 12, 2024
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRIInka Ristow, Michael G Kaul, Maria Stark, et al.
Journal of Neuro-Oncology|April 10, 2012
Overactivation of Ras signaling pathway in CD133+ MPNST cellsEmma Borrego-Diaz, Kaoru Terai, Kristina Lialyte, et al.
Plos One|April 29, 2020
The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1Lennart Well, Anna Jaeger, Hildegard Kehrer-Sawatzki, et al.
Clinical Biochemistry|December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosisMiriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Plos One|November 10, 2012
Impaired Pten expression in human malignant peripheral nerve sheath tumoursMaren Bradtmöller, Christian Hartmann, Jan Zietsch, et al.
Plos One|May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosisScott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Pageof 8

Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Carcinogenesis|December 17, 2005
Mutation and expression of PDGFRA and KIT in malignant peripheral nerve sheath tumors, and its implications for imatinib sensitivityNikola Holtkamp, Ali Fuat Okuducu, Jana Mucha, et al.
EJNMMI Research|December 27, 2024
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumours in neurofibromatosis type 1 - intraindividual comparison of positron emission computed tomography and diffusion-weighted magnetic resonance imagingInka Ristow, Ivayla Apostolova, Michael G Kaul, et al.
Neuro-Oncology|November 30, 2018
Differentiation of peripheral nerve sheath tumors in patients with neurofibromatosis type 1 using diffusion-weighted magnetic resonance imagingLennart Well, Johannes Salamon, Michael G Kaul, et al.
Neuro-Oncology Advances|March 12, 2024
Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRIInka Ristow, Michael G Kaul, Maria Stark, et al.
Journal of Neuro-Oncology|April 10, 2012
Overactivation of Ras signaling pathway in CD133+ MPNST cellsEmma Borrego-Diaz, Kaoru Terai, Kristina Lialyte, et al.
Plos One|April 29, 2020
The effect of pregnancy on growth-dynamics of neurofibromas in Neurofibromatosis type 1Lennart Well, Anna Jaeger, Hildegard Kehrer-Sawatzki, et al.
Clinical Biochemistry|December 25, 2012
Plasma S100β is not a useful biomarker for tumor burden in neurofibromatosisMiriam J Smith, Sonia Esparza, Vanessa L Merker, et al.
Plos One|November 10, 2012
Impaired Pten expression in human malignant peripheral nerve sheath tumoursMaren Bradtmöller, Christian Hartmann, Jan Zietsch, et al.
Plos One|May 5, 2012
Quantitative assessment of whole-body tumor burden in adult patients with neurofibromatosisScott R Plotkin, Miriam A Bredella, Wenli Cai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 27, 2010
Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullinTrent R Hummel, Walter J Jessen, Shyra J Miller, et al.
Pageof 8